Early-stage venture capital firm Atlas Venture has entered into a multi-year collaboration with biopharmaceutical company Shire Human Genetic Therapies. Shire and Atlas will work together to identify strategic investments for early stage venture creation around rare genetic diseases.
PRESS RELEASE
Read more »


